These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 35593963)
1. Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Yang S; Tong Y; Chen L; Yu W Mol Biomed; 2022 May; 3(1):15. PubMed ID: 35593963 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network. Li W; Yang S; Xu P; Zhang D; Tong Y; Chen L; Jia B; Li A; Lian C; Ru D; Zhang B; Liu M; Chen C; Fu W; Yuan S; Gu C; Wang L; Li W; Liang Y; Yang Z; Ren X; Wang S; Zhang X; Song Y; Xie Y; Lu H; Xu J; Wang H; Yu W EBioMedicine; 2022 Feb; 76():103861. PubMed ID: 35124429 [TBL] [Abstract][Full Text] [Related]
3. Hymecromone: a clinical prescription hyaluronan inhibitor for efficiently blocking COVID-19 progression. Yang S; Ling Y; Zhao F; Li W; Song Z; Wang L; Li Q; Liu M; Tong Y; Chen L; Ru D; Zhang T; Zhou K; Zhang B; Xu P; Yang Z; Li W; Song Y; Xu J; Zhu T; Shan F; Yu W; Lu H Signal Transduct Target Ther; 2022 Mar; 7(1):91. PubMed ID: 35304437 [TBL] [Abstract][Full Text] [Related]
4. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
5. Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19. Yang S; Chen L; Tong Y; Yu W Acta Pharm Sin B; 2022 Jul; 12(7):3195-3197. PubMed ID: 35433240 [No Abstract] [Full Text] [Related]
6. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors. Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760 [TBL] [Abstract][Full Text] [Related]
9. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents. Nandi S; Roy H; Gummadi A; Saxena AK Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
13. Potential role of IFN-α in COVID-19 patients and its underlying treatment options. Yang L; Wang J; Hui P; Yarovinsky TO; Badeti S; Pham K; Liu C Appl Microbiol Biotechnol; 2021 May; 105(10):4005-4015. PubMed ID: 33950278 [TBL] [Abstract][Full Text] [Related]
14. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies. Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866 [TBL] [Abstract][Full Text] [Related]
15. [Assessment of the effectiveness of early treatment in SARS-CoV-2 infection]. Płusa T Pol Merkur Lekarski; 2021 Dec; 49(294):394-400. PubMed ID: 34919080 [TBL] [Abstract][Full Text] [Related]
16. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Yin J; Li C; Ye C; Ruan Z; Liang Y; Li Y; Wu J; Luo Z Comput Struct Biotechnol J; 2022; 20():824-837. PubMed ID: 35126885 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM Elife; 2022 Jan; 11():. PubMed ID: 35072628 [TBL] [Abstract][Full Text] [Related]
18. A review of the latest research on M Yang H; Yang J RSC Med Chem; 2021 Jul; 12(7):1026-1036. PubMed ID: 34355175 [TBL] [Abstract][Full Text] [Related]
19. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993 [TBL] [Abstract][Full Text] [Related]